Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Sponsor and Collaborators
University of Pittsburgh
National Cancer Institute (NCI)

Contact

Contact: Athanassios Argiris, MD
(412) 623-4083
[email protected]

Contact: Rita Johnson, RN
(412) 547-5871
[email protected]


Continue Reading

Principal Investigator
Athanassios Argiris, MD ECOG

ClinicalTrials.gov Identifier
NCT00409565